Bdf Gestion Abbott Laboratories Transaction History
Bdf Gestion
- $894 Billion
- Q2 2025
A detailed history of Bdf Gestion transactions in Abbott Laboratories stock. As of the latest transaction made, Bdf Gestion holds 58,761 shares of ABT stock, worth $7.89 Million. This represents 0.89% of its overall portfolio holdings.
Number of Shares
58,761
Previous 65,164
9.83%
Holding current value
$7.89 Million
Previous $8.64 Billion
7.54%
% of portfolio
0.89%
Previous 0.94%
Shares
3 transactions
Others Institutions Holding ABT
# of Institutions
3,582Shares Held
1.38BCall Options Held
9.71MPut Options Held
8.86M-
Vanguard Group Inc Valley Forge, PA170MShares$22.8 Billion0.42% of portfolio
-
Black Rock Inc. New York, NY131MShares$17.6 Billion0.31% of portfolio
-
State Street Corp Boston, MA77.7MShares$10.4 Billion0.44% of portfolio
-
Capital International Investors Los Angeles, CA66.8MShares$8.97 Billion1.82% of portfolio
-
Capital Research Global Investors Los Angeles, CA50.7MShares$6.81 Billion1.53% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $235B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...